PNC-27
PNC27
Think of it as an investigational peptide studied in cancer-cell research.
PNC-27 is a lab-made peptide studied in cell-culture cancer research. It has not been tested in humans, and nothing here describes a treatment. In laboratory studies it appears to target a protein found on the surface of certain cancer cells but not on healthy ones, and in those studies it has been observed to disrupt the cancer-cell membrane.
In cell-based experiments, researchers have reported activity against several cancer cell lines, including leukemia and breast cancer models, with limited effect on healthy cells in the same tests. These are early preclinical findings only. PNC-27 remains an investigational research compound and has not been evaluated for safety or efficacy in people.
Who it's for
- Researchers investigating novel cancer therapies
- Science enthusiasts interested in cutting-edge cancer research
- People curious about potential future cancer treatments
Probably not for you if…
- Anyone looking for a proven cancer treatment
- Those expecting FDA-approved or clinically tested options
- Individuals seeking immediate solutions for cancer therapy
Editorial summary for research context · Not medical advice
Mechanism of Action
PNC-27 is a synthetic chimeric peptide combining residues 12-26 of the p53 protein (the HDM-2 binding region) with a membrane-penetrating leader sequence derived from penetratin. Preclinical research reports that PNC-27 binds HDM-2 that is aberrantly expressed on the surface membrane of cancer cells, forming transmembrane pores that trigger necrotic cell death selectively in malignant cells while sparing normal cells that do not express membrane HDM-2. PNC-27 is strictly a preclinical research compound with no human clinical efficacy data and no FDA approval for any indication.
Researched Benefits
Selective tumor-cell membranolysis (preclinical)
In-vitro studies across multiple human cancer cell lines (leukemia, melanoma, pancreatic, breast) report selective necrosis of malignant cells versus paired normal controls.
- [Michl et al. 2006]
- [Sarafraz-Yazdi et al. 2010]
Xenograft tumor reduction (preclinical)
Mouse xenograft models of pancreatic and acute myeloid leukemia report tumor regression or growth delay with systemic PNC-27 administration.
- [Sarafraz-Yazdi et al. 2015]
Research Protocols
The following dosing ranges have appeared in published research protocols. Presented for informational purposes only, not a recommendation for human use.
Preclinical research use only
- Dosage
- -
- Frequency
- not established
- Timing
- not established
- Cycle
- -
No validated human dosing exists. All published work is in cell culture and rodent models. This is a preclinical research compound; PNC-27 has not been tested in human clinical trials and should not be used in humans for any therapeutic purpose.
Reported Side Effects
- Human safety profile is unknown, no clinical trial data exist
- Potential for off-target membrane effects in tissues that transiently express HDM-2
- Immunogenicity risk from chimeric peptide (theoretical)
- Injection-site effects (animal data)
Contraindications
- All human use outside a regulated preclinical/IRB-approved investigational setting
- Pregnancy and lactation
- Pediatric use
- Any patient with active medical conditions, no safety data exist
Vendor Pricing
Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.
Gear + Companions
Reconstitution supplies and research-backed supplement companions for PNC-27. Editorial picks only, we earn a commission through Amazon on the click, no sponsorship.
Gear you'll need
· Reconstitution + storage essentialsBacteriostatic Water 30mL (0.9% Benzyl Alcohol)
Empower Pharmacy / generic medical supply
Reconstitutes every lyophilized peptide. 28-day viability refrigerated.
Insulin Syringes 31G × 5/16" × 0.5mL (100 count)
EasyTouch
31G × 0.5mL insulin syringes — the default size for sub-0.25mL peptide doses.
Alcohol Prep Pads (Sterile, 200 count)
Dynarex
Sterile 70% IPA prep pads — one per vial stopper + one per injection site.
1-Quart Sharps Disposal Container
BD / Becton Dickinson
FDA-cleared sharps container — pharmacies won't accept improvised disposal.
As an Amazon Associate we earn from qualifying purchases · Disclosed per FTC guidelines
Top Videos
Curated from YouTube, refreshed weekly. Stacked doesn't host or endorse external content.
10:51A Supplement ACTUALLY Proven to Prevent Cancer!
Physionic
532.7K views · 10:51 · 7 months ago
10:0211 Peptides Just Got Greenlit by the FDA (Here's What Changed)
This Is Not Covered - Dr. Ashley Froese
505.8K views · 10:02 · 3 months ago
10:37Understanding Pancreatic Cancer
Zero To Finals
426.1K views · 10:37 · 3 years ago
7:15Doctor Explains Your RISK of Cancer From Popular Peptides
This Is Not Covered - Dr. Ashley Froese
210.8K views · 7:15 · 8 months ago
7:50Doctor Reveals 3 Mitochondrial Fixes That Boost Energy
This Is Not Covered - Dr. Ashley Froese
188.7K views · 7:50 · 9 months ago
Research Papers
PNC-27, a chimeric p53-penetratin peptide, binds to HDM-2 in cancer cell membranes to induce necrosis
Sarafraz-Yazdi E, et al. · Proceedings of the National Academy of Sciences USA · 2010
PubMed 20080731 →Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes
Michl J, et al. · Proceedings of the National Academy of Sciences USA · 2006
PubMed 17033002 →
Frequently Asked
- What is PNC-27?
- PNC-27 is a other studied in laboratory research. This profile covers its researched mechanism of action, study context, reported side-effect profile, and current vendor pricing. For research purposes only; not medical advice.
- Is PNC-27 legal to buy?
- PNC-27 is sold strictly for laboratory and research use and is not approved by the FDA for human consumption. Legal status and import rules vary by country and are the buyer's responsibility.
- How much does PNC-27 cost?
- Compare live $/mg, total price, stock, and each vendor's Stacked Score for PNC-27 on its price page. Stacked does not sell peptides; it links out to vetted research vendors.